IdentificationGeneric Name(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acidDrugBank Accession NumberDB03121BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid (DB03121)× CloseWeightAverage: 309.3591 Monoisotopic: 309.136493479 Chemical FormulaC19H19NO3SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUPhospholipase A2, membrane associatedNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassIndoles and derivativesSub ClassIndolyl carboxylic acids and derivativesDirect ParentIndole-3-acetic acid derivativesAlternative ParentsN-alkylindoles / 3-alkylindoles / Anisoles / Alkyl aryl ethers / Substituted pyrroles / Benzene and substituted derivatives / Heteroaromatic compounds / Monocarboxylic acids and derivatives / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 5 moreSubstituents3-alkylindole / Alkyl aryl ether / Anisole / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Ether / Heteroaromatic compound / Hydrocarbon derivative / Indole / Indole-3-acetic acid derivative / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / N-alkylindole / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Pyrrole / Substituted pyrrole


 show 15 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS number59283-35-1InChI KeyZEKCBTQHDTUHRJ-UHFFFAOYSA-NInChIInChI=1S/C19H19NO3/c1-13-16(11-19(21)22)17-10-15(23-2)8-9-18(17)20(13)12-14-6-4-3-5-7-14/h3-10H,11-12H2,1-2H3,(H,21,22)IUPAC Name2-(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acidSMILESCOC1=CC2=C(C=C1)N(CC1=CC=CC=C1)C(C)=C2CC(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound1372PubChem Substance46505875ChemSpider1331BindingDB50055737ChEMBLCHEMBL148756ZINCZINC000001685326PDBe LigandI3NPDB Entries1dcyClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0101 mg/mLALOGPSlogP3.82ALOGPSlogP3.7ChemaxonlogS-4.5ALOGPSpKa (Strongest Acidic)4.43ChemaxonpKa (Strongest Basic)-4.8ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count3ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area51.46 Å2ChemaxonRotatable Bond Count5ChemaxonRefractivity89.57 m3·mol-1ChemaxonPolarizability33.54 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9956Blood Brain Barrier+0.9693Caco-2 permeable+0.7814P-glycoprotein substrateNon-substrate0.5087P-glycoprotein inhibitor INon-inhibitor0.7332P-glycoprotein inhibitor IINon-inhibitor0.6728Renal organic cation transporterNon-inhibitor0.5469CYP450 2C9 substrateNon-substrate0.7492CYP450 2D6 substrateNon-substrate0.5889CYP450 3A4 substrateSubstrate0.5764CYP450 1A2 substrateInhibitor0.8883CYP450 2C9 inhibitorNon-inhibitor0.5897CYP450 2D6 inhibitorNon-inhibitor0.8141CYP450 2C19 inhibitorInhibitor0.7365CYP450 3A4 inhibitorNon-inhibitor0.5916CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.7091Ames testNon AMES toxic0.6564CarcinogenicityNon-carcinogens0.9429BiodegradationNot ready biodegradable0.9521Rat acute toxicity2.6349 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9359hERG inhibition (predictor II)Non-inhibitor0.7355  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)13600N/AN/AA30104


 Details


 Binding Properties1. Phospholipase A2, membrane associatedKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPhospholipid bindingSpecific FunctionThought to participate in the regulation of the phospholipid metabolism in biomembranes including eicosanoid biosynthesis. Catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-ph...Gene NamePLA2G2AUniprot IDP14555Uniprot NamePhospholipase A2, membrane associatedMolecular Weight16082.525 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 